Todd Horich
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Todd Horich is currently SVP-Commercial Operations & Marketing at Supernus Pharmaceuticals, Inc. since 2023.
Formerly, Dr. Horich was Marketing Director at Vanda Pharmaceuticals, Inc. from 2006 to 2009 and Marketing Director at MedImmune LLC.
Education includes an MBA from the University of Baltimore and undergraduate, graduate, and doctorate degrees from the University of Maryland.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/04/2026 | 26.502 ( 0,05 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Ventas & Marketing | 31/05/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Ventas & Marketing | 01/01/2009 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Vanda Pharmaceuticals, Inc.
Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
University of Baltimore
University of Baltimore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.